+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Next Generation Sequencing"

From
From
Carrier Screening - Global Strategic Business Report - Product Thumbnail Image

Carrier Screening - Global Strategic Business Report

  • Report
  • April 2025
  • 173 Pages
  • Global
From
From
Cancer Gene Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Gene Therapy - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Epigenetics - Global Strategic Business Report - Product Thumbnail Image

Epigenetics - Global Strategic Business Report

  • Report
  • April 2025
  • 427 Pages
  • Global
From
Nucleic Acid Testing - Global Strategic Business Report - Product Thumbnail Image

Nucleic Acid Testing - Global Strategic Business Report

  • Report
  • April 2025
  • 372 Pages
  • Global
From
Whole Exome Sequencing - Global Strategic Business Report - Product Thumbnail Image

Whole Exome Sequencing - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Genotyping - Global Strategic Business Report - Product Thumbnail Image

Genotyping - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
Genomics - Global Strategic Business Report - Product Thumbnail Image

Genomics - Global Strategic Business Report

  • Report
  • April 2025
  • 292 Pages
  • Global
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Thumbnail Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
From
Oligonucleotide Synthesis - Global Strategic Business Report - Product Thumbnail Image

Oligonucleotide Synthesis - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Nucleic Acid Labeling - Global Strategic Business Report - Product Thumbnail Image

Nucleic Acid Labeling - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
From
Human Identification - Global Strategic Business Report - Product Thumbnail Image

Human Identification - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
HLA Typing for Transplant - Global Strategic Business Report - Product Thumbnail Image

HLA Typing for Transplant - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
From
DNA Forensic Solutions - Global Strategic Business Report - Product Thumbnail Image

DNA Forensic Solutions - Global Strategic Business Report

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Sequencing Reagents - Global Strategic Business Report - Product Thumbnail Image

Sequencing Reagents - Global Strategic Business Report

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Loading Indicator

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species. The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more